Esmilkrys Ramirez
Obesity Medicine in Chicago, Illinois
Practice Details
Chicago, IL 60641
Specialty taxonomies on file (2)
- Internal Medicine
- PrimaryObesity MedicinePreventive Medicine, Obesity Medicine
All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.
About This Clinician
This clinician is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Chicago are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.
Locally, this is 1 of 5 Obesity Medicine (Preventive Medicine) practices in Chicago carrying this exact taxonomy in our directory.
What to expect at an Obesity Medicine visit
A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:
- •A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
- •A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
- •Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
- •A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.
This is general guidance for obesity medicine practices, not a description of Esmilkrys Ramirez's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 773-622-4400.
GLP-1 access in Chicago, Illinois
About 32.4% of Illinois adults have obesity (BMI 30+), ranking the state #26 of 50 (CDC BRFSS). Our directory currently lists 314 GLP-1-relevant clinics in Chicago. If a cash-pay route makes more sense, compounded semaglutide through Illinois telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.
Explore more Illinois options on the best Illinois GLP-1 providers page, browse every Chicago listing in the Chicago clinic directory, or read the Illinois Medicaid GLP-1 coverage & prior-authorization guide.
Related Practices in Chicago
Other Chicago listings in the same directory tier:
Telehealth Alternative
Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Illinois addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Illinois telehealth partners:
Featured Partners · Chicago
Featured GLP-1 providers serving Chicago
No insurance needed
reader-supported
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
- Top pick7.6Get started →Save $1,099.01/mo vs Wegovy
Compounded from
$249.99/mo
- 8.3Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
- 7.4Get started →Save $1,150/mo vs Wegovy
Compounded from
$199/mo
- 6.2Get started →Save $1,202/mo vs Wegovy
Compounded from
$147/mo
- 8.2Get started →Save $937/mo vs Zepbound
Compounded from
$149/mo
- 6.9Get started →Save $1,100/mo vs Wegovy
Compounded from
$249/mo
| Provider | Compounded from | Save vs brand | |
|---|---|---|---|
7.6MaximusTop pick | $249.99/mo | Save $1,099.01/mo | Get started → |
8.3Found | $99/mo | Save $1,250/mo | Get started → |
7.4Breeze Meds | $199/mo | Save $1,150/mo | Get started → |
6.2Wellorithm | $147/mo | Save $1,202/mo | Get started → |
8.2Gala | $149/mo | Save $937/mo | Get started → |
6.9TMates | $249/mo | Save $1,100/mo | Get started → |
See more Chicago options on the Chicago clinic directory, our Chicago GLP-1 telehealth page, or compare the best semaglutide providers nationwide.
Learn more about the medications most commonly prescribed by Chicago obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.